Quote:

---

And don’t rule out a blockbuster deal just yet: Malik said that if a larger opportunity comes up, Pfizer is willing to pounce. Several large transactions, at $50 billion or more, are likely to occur next year, PwC predicted last week.

“If we see a larger acquisition opportunity that is strategic and we deem as value-creating, we certainly have the very solid balance sheet we can utilize to pursue that,” Malik said. “We will not speak in absolutes, and we never say never because we know circumstances can change.”

---